4//SEC Filing
Meline David W 4
Accession 0001127602-22-008037
CIK 0001682852other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:58 PM ET
Size
7.4 KB
Accession
0001127602-22-008037
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
Meline David W
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2022-03-01+6,415→ 6,415 totalExercise: $0.00→ Common Stock (6,415 underlying) - Award
Stock Option (Right to Buy)
2022-03-01+26,020→ 26,020 totalExercise: $149.52From: 2023-03-01Exp: 2032-03-01→ Common Stock (26,020 underlying)
Footnotes (2)
- [F1]25% of this option will vest and become exercisable on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- [F2]25% of the shares subject to this restricted stock unit award will vest on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
Documents
Issuer
Moderna, Inc.
CIK 0001682852
Entity typeother
Related Parties
1- filerCIK 0001444612
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:58 PM ET
- Size
- 7.4 KB